Selwyn holds a B. Pharm degree from Rhodes University as well as a Masters in Business Science from the Witwatersrand University.He held the position of Group Chief Executive Officer of Litha Healthcare Group Limited from May 2010 until June 2015 when Endo International plc, successfully acquired the company. Previously, he held the long standing position of CEO to Litha Healthcare Holdings and The Biovac Institute.Under his leadership Litha Healthcare Holdings concluded strategic partnerships with the Department of Health, ultimately becoming the preferred supplier of vaccines to the South African DOH and SADEC region for 15 consecutive years (1994-2009).As a result of these significant partnerships and his visionary style of leadership, the company expanded and tapped into other health segments such as private hospitals; pharmaceutical; surgical; and private diagnostic.